MIT logo
June 11-13, 2019 • MIT, Cambridge, MA
ucl
 
Images
 

Agenda Day 2: Wednesday, June 12
Workshop schedule as of 5.31.19 – sessions, times, and speakers are subject to change.

line
  Time Event
line
  8:30 – 9:00 AM Continental Breakfast
line
  9:00 – 10:00 AM Challenges and Opportunities in Vaccine Manufacturing
Tarit Mukhopadhyay view bio
Associate Vice President, Vaccine Process Research & Development, Merck & Co., Inc.
line
  10:00 – 11:00 AM Bioprocessing for Vaccine Viruses and Vectors view abstract
John Aunins
view bio
Executive Vice President & Chief Technology Officer, Seres Therapeutics, Inc.
line
  11:00 AM – 12:30 PM Influenza Vaccine Development and Manufacture view abstract
Matthew Downham view bio
Associate Director, AstraZeneca

line
  12:30 – 1:30 PM Lunch
line
  1:30 – 2:30 PM Lessons from the MIT Consortium on Adventitious Agent Contamination in Biomanufacturing view abstract
Paul W. Barone view bio
Director, Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), Center for Biomedical Innovation, Massachusetts Institute of Technology
line
  2:30 – 3:30 PM Development of Capsular Polysaccharide Conjugate Vaccines view abstract
Steve A. Kolodziej view bio
Associate Research Fellow, Pfizer, Inc.
line
  3:30 – 4:00 PM Refreshment Break
line
  4:00 – 5:00 PM Quality Control of Human Viral Vaccines: Reducing the Risk of Viral and Microbial Contamination view abstract
Martin Wisher view bio
Senior Regulatory Consultant, Quality & Regulatory Management, MilliporeSigma
line
  5:00 – 6:00 PM Introduction to the Future Vaccine Manufacturing Research Hub (Vax-Hub) view abstract
Stefanie Frank view bio
Lecturer in Synthetic Biology; Modular Training for the Bioprocess Industries (MBI), Module Leader Vaccine Bioprocess Development and Commercialisation, University College London
line
  6:30 – 7:30 PM Networking Reception
line
  Agenda Day 1 Agenda Day 2 Agenda Day 3      
MIT CBI MBI